Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer
Clinical trial NCT03770689 · COMPLETED
Trial details
- NCT number
- NCT03770689
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-20
- Primary completion
- 2021-06-21
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.